Pasar al contenido principal

MODELADO DEL CEREBRO MULTIESCALA Y NUEVOS BIOMARCADORES DE REGISTROS CEREBRALES PARA LA INFERENCIA DE PARAMETROS DE ACTIVIDAD DEL CIRCUITO NEURONAL (MS-BRAINMARKER)

PID2022-139055OA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE GRANADA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Combining aperiodic 1/f slopes and brain simulation: an EEG/MEG proxy marker of excitation/inhibition imbalance in Alzheimer's disease

  • Martínez‐Cañada, Pablo
  • Perez‐Valero, Eduardo
  • Minguillon, Jesus
  • Pelayo, Francisco
  • López‐Gordo, Miguel A.
  • Morillas, Christian
Introduction. Accumulation and interaction of amyloid-beta (Aβ) and tau proteins during progression of Alzheimer's disease (AD) are shown to tilt neuronal circuits away from balanced excitation/inhibition (E/I). Current available techniques for noninvasive interrogation of E/I in the intact human brain, for example, magnetic resonance spectroscopy (MRS), are highly restrictive (i.e., limited spatial extent), have low temporal and spatial resolution and suffer from the limited ability to distinguish accurately between different neurotransmitters complicating its interpretation. As such, these methods alone offer an incomplete explanation of E/I. Recently, the aperiodic component of neural power spectrum, often referred to in the literature as the ‘1/f slope’, has been described as a promising and scalable biomarker that can track disruptions in E/I potentially underlying a spectrum of clinical conditions, such as autism, schizophrenia, or epilepsy, as well as developmental E/I changes as seen in aging. Methods. Using 1/f slopes from resting-state spectral data and computational modeling, we developed a new method for inferring E/I alterations in AD. Results. We tested our method on recent freely and publicly available electroencephalography (EEG) and magnetoencephalography (MEG) datasets of patients with AD or prodromal disease and demonstrated the method's potential for uncovering regional patterns of abnormal excitatory and inhibitory parameters. Discussion. Our results provide a general framework for investigating circuit-level disorders in AD and developing therapeutic interventions that aim to restore the balance between excitation and inhibition., We thank members of the NeuroEngineering and Computing (NECo) Lab (University of Granada, Spain) for their invaluable discussions and feedback on this work. This work was conducted using the MRC Dementias Platform UK (DPUK). DPUK is a Public Private Partnership funded by the Medical Research Council (MR/L023784/1 and MR/009076/1). For further information on this resource visit www.dementiasplatform.uk. This project has received funding from MCIN / AEI / 10.13039/501100011033 / FEDER, EU (grants PID2022-137461NB-C31 to C.M., PID2022-139055OA-I00 to P.M.C. and PID2021-128529OA-I00 to M.A.L.G.), from “Junta de Andalucía”—Postdoctoral Fellowship Programme PAIDI 2020 (to J.M.) and 2021 (to P.M.C.), from “Junta de Andalucía”—Projects for Excellence Research (grant PROYEXCEL_00084 to M.A.L.G.) and from University of Granada – “Plan Propio de Investigación” 2021 and 2022 (grant PPJIA2022.33 to P.M.C. and J.M., PP2022.PP.33 to J.M. and PP2021.PP-28 to M.A.L.G). The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Combining aperiodic 1/f slopes and brain simulation: an EEG/MEG proxy marker of excitation/inhibition imbalance in Alzheimer's disease

  • Martínez‐Cañada, Pablo
  • Perez‐Valero, Eduardo
  • Minguillon, Jesus
  • Pelayo, Francisco
  • López‐Gordo, Miguel A.
  • Morillas, Christian
Introduction. Accumulation and interaction of amyloid-beta (Aβ) and tau proteins during progression of Alzheimer's disease (AD) are shown to tilt neuronal circuits away from balanced excitation/inhibition (E/I). Current available techniques for noninvasive interrogation of E/I in the intact human brain, for example, magnetic resonance spectroscopy (MRS), are highly restrictive (i.e., limited spatial extent), have low temporal and spatial resolution and suffer from the limited ability to distinguish accurately between different neurotransmitters complicating its interpretation. As such, these methods alone offer an incomplete explanation of E/I. Recently, the aperiodic component of neural power spectrum, often referred to in the literature as the ‘1/f slope’, has been described as a promising and scalable biomarker that can track disruptions in E/I potentially underlying a spectrum of clinical conditions, such as autism, schizophrenia, or epilepsy, as well as developmental E/I changes as seen in aging. Methods. Using 1/f slopes from resting-state spectral data and computational modeling, we developed a new method for inferring E/I alterations in AD. Results. We tested our method on recent freely and publicly available electroencephalography (EEG) and magnetoencephalography (MEG) datasets of patients with AD or prodromal disease and demonstrated the method's potential for uncovering regional patterns of abnormal excitatory and inhibitory parameters. Discussion. Our results provide a general framework for investigating circuit-level disorders in AD and developing therapeutic interventions that aim to restore the balance between excitation and inhibition., We thank members of the NeuroEngineering and Computing (NECo) Lab (University of Granada, Spain) for their invaluable discussions and feedback on this work. This work was conducted using the MRC Dementias Platform UK (DPUK). DPUK is a Public Private Partnership funded by the Medical Research Council (MR/L023784/1 and MR/009076/1). For further information on this resource visit www.dementiasplatform.uk. This project has received funding from MCIN / AEI / 10.13039/501100011033 / FEDER, EU (grants PID2022-137461NB-C31 to C.M., PID2022-139055OA-I00 to P.M.C. and PID2021-128529OA-I00 to M.A.L.G.), from “Junta de Andalucía”—Postdoctoral Fellowship Programme PAIDI 2020 (to J.M.) and 2021 (to P.M.C.), from “Junta de Andalucía”—Projects for Excellence Research (grant PROYEXCEL_00084 to M.A.L.G.) and from University of Granada – “Plan Propio de Investigación” 2021 and 2022 (grant PPJIA2022.33 to P.M.C. and J.M., PP2022.PP.33 to J.M. and PP2021.PP-28 to M.A.L.G). The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.